Pilates may protect bones in breast cancer survivors on hormone therapy

NCT ID NCT07334626

Completed Disease control Sponsor: Benha University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 24, 2026 · Updated 2 times

Summary

This study tests whether doing Pilates exercises three times a week for 12 weeks can improve bone density in breast cancer survivors aged 40-60 who are taking hormone therapy (aromatase inhibitors). These women are at higher risk for bone loss and osteoporosis. The trial will measure changes in bone mineral density and quality of life in 60 participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Pilates exercises
What this could lead to: If it works, this could offer a simple, drug-free way to help breast cancer survivors maintain bone strength while on hormone therapy.
What could go wrong: This is a small, early-stage trial with only 60 participants over 12 weeks. Bone changes may be too small to matter, and results may not apply to all survivors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AROMATASE INHIBITORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Bone Diseases, Metabolic breast cancer breast neoplasm osteoporosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AROMATASE INHIBITORS BREAST CANCER BREAST CANCER SURVIVORS OSTEOPOROSIS OR OSTEOPENIA PILATES EXERCISE

Contacts and locations

Locations

Outpatient clinic, faculty of Physical Therapy, Benha university

Banhā, Benha, 11603, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.